Results 251 to 260 of about 320,436 (348)
Unexpected occurrence of anti-B antibodies in a patient with A2B blood group: a case report and review of literature. [PDF]
Kalhori F, Babakhani M, Sayyadi M.
europepmc +1 more source
Pyropheophytin a accompanies pheophytin a in darkened light grown cells of Euglena [PDF]
Rüdiger, W. +4 more
core
Exploring tear fluid biomarkers and the ocular surface in thyroid eye disease
Abstract Purpose To examine ocular surface changes and inflammatory tear fluid biomarkers in patients with thyroid eye disease (TED). Methods We included 106 Graves' disease (GD) patients (36 without TED, 32 with active and 38 with inactive TED) and 106 age‐ and sex‐matched healthy subjects for ophthalmological evaluation, including ocular surface ...
Mikael Thomassen Neset +13 more
wiley +1 more source
Clonal hematopoiesis driven by Dnmt3a mutations promotes metabolic disease development in mice. [PDF]
Yan B +9 more
europepmc +1 more source
Sustainability in Healthcare: The Role of Digital Technologies for Improving Patient Engagement
ABSTRACT Sustainability in healthcare is getting considerable research attention as systems worldwide tend to balance environmental, social, and economic factors. In this context, digital technologies have demonstrated significant potential to enhance engagement among different consumer groups across various industries.
Francesco Schiavone +4 more
wiley +1 more source
Recognize, Monitor, Treat: A Comprehensive Approach to Improving Resistant Hypertension Care. [PDF]
Vardanyan L +4 more
europepmc +1 more source
The definition of ABO factors in transplantation: Relation to other humoral antibody states [PDF]
Banner, B +7 more
core
The present study revealed the neuroprotective effect of ginsenoside Rg1 against cerebral ischemia–reperfusion injury through inhibition of mitophagy via blocking mitophagosome‐lysosome fusion both in vivo and in vitro models. ABSTRACT Ginsenoside Rg1 has shown promise in ameliorating cerebral ischemia–reperfusion injury (CIRI).
Lin Ai +11 more
wiley +1 more source

